High risk of malignancy in mosaic variegated aneuploidy syndrome

被引:60
作者
Jacquemont, S
Bocéno, M
Rival, JM
Méchinaud, F
David, A
机构
[1] Serv Genet Med Hop Mere Enfant, Untei Genet Clin, Nantes, France
[2] CHU Nantes, Serv Genet Med, Unite Cytogenet Antenatal, F-44035 Nantes 01, France
[3] Hop Mere Enfant, Serv Oncol Pediat, Nantes, France
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2002年 / 109卷 / 01期
关键词
variegated aneuploidy; mosaicism; myelodysplasia; neoplasia;
D O I
10.1002/ajmg.10281
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Fourteen cases of mosaic variegated aneuploidy (MVA) syndrome have been reported in the last 10 years. The phenotype of this rare condition has been quite consistent: severe microcephaly, growth deficiency, mild physical anomalies, and mental retardation. We describe here a young boy in whom MVA syndrome is associated to myelodysplasia with a monosomy 7 bone marrow clone. At the age of 3 years, myelodysplasia progressed to an acute lymphoblastic leukemia, and the patient died soon after. Several syndromes with short stature and severe microcephaly, such as the Seckel and Nijmegen syndromes, comprise hematological findings and chromosome instability. However, chromosome instability was not comfirmed in our patient. MVA with hematological findings has not been reported before, but 3 patients of 14 (21%) have developed a malignancy (rhabdomyosarcoma, acute lymphoblastic leukemia, and nephroblastoma). Therefore, we propose that MVA is a condition predisposing to neoplasia. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:17 / 21
页数:5
相关论文
共 25 条
[1]  
Abou-Zahr F, 1999, AM J MED GENET, V83, P388, DOI 10.1002/(SICI)1096-8628(19990423)83:5<388::AID-AJMG9>3.0.CO
[2]  
2-1
[3]  
BITOUN P, 1994, ANN GENET-PARIS, V37, P75
[4]   DO SOME PATIENTS WITH SECKEL SYNDROME HAVE HEMATOLOGICAL PROBLEMS AND/OR CHROMOSOME BREAKAGE [J].
BUTLER, MG ;
HALL, BD ;
MACLEAN, RN ;
LOZZIO, CB .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1987, 27 (03) :645-649
[5]  
DerKaloustian VM, 1996, AM J MED GENET, V65, P21, DOI 10.1002/(SICI)1096-8628(19961002)65:1<21::AID-AJMG3>3.0.CO
[6]  
2-0
[7]  
Flejter WL, 1998, AM J MED GENET, V75, P45, DOI 10.1002/(SICI)1096-8628(19980106)75:1<45::AID-AJMG10>3.0.CO
[8]  
2-S
[9]  
Kajii T, 1998, AM J MED GENET, V78, P245, DOI 10.1002/(SICI)1096-8628(19980707)78:3<245::AID-AJMG7>3.0.CO
[10]  
2-O